Her2 mRNA-targeted peptide nucleic acid PET imaging agent (Molecular Targeting Technologies)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHer2 mRNA-targeted peptide nucleic acid PET imaging agent (Molecular Targeting Technologies)
Drug Alias Name64Cu-PNA Her-2 mRNA-targeted (Molecular Targeting Technologies)
ClassificationBiologicsRadiation-emitting products
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Targeting Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Targeting Technologies Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A